NextCompany

Licensed New Jersey Behavioral Health Platform — SUD Detox, Residential & Mental Health Outpatient

New Jersey Behavioral Health Platform with Expansion Underway

On NextCompany since August 27, 2026 (today)

NJ area
Financial summary
Asking price
N/A
Gross revenue
$13,500,000
Cash flow (SDE)
N/A
EBITDA
$2,900,000

Figures come from the listing party and are not verified or guaranteed by NextCompany. Parts of this page are AI-generated and may contain errors. Verify everything before relying on it. See the Buyer Terms.

Business overview

The platform delivers SUD medical detox, residential treatment, and mental health outpatient services in Central New Jersey. It maintains a detox and residential campus plus a separately licensed outpatient site. A 40-bed expansion undergoes build-out. Revenue reached $13,500,000 in 2025 with $2,900,000 EBITDA. Ownership seeks a strategic partner. The company keeps mental health outpatient services active and growing.

Who is a good fit for this business

  • Strategic buyers pursue licensed behavioral health platforms in New Jersey.
  • Investors support a 40-bed detox and residential expansion.
  • Partners accept a transition period with current ownership.

Details

Frequently Asked Questions

The platform provides SUD medical detox, residential treatment, and mental health outpatient services. It operates across multiple Central New Jersey sites. A pre-revenue facility remains in late-stage NJ DOH review.

Revenue reached $13,500,000 in 2025. Adjusted EBITDA totaled $2,900,000. January through April 2026 annualizes to $14.1 million revenue and $3.6 million EBITDA.

Ownership seeks a strategic or capital partner to scale through bed expansion and operational repositioning. The historically marketed SUD outpatient program is winding down. Mental health outpatient services continue to grow.

Ownership remains open to a transition period of mutually agreed length. The platform includes a detox and residential campus plus outpatient locations.

Similar businesses